TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
CCCC

C4 Therapeutics Inc

Healthcare · Biotechnology

3.30$ -2.7% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement CCCC
Line item 2018 2019 2020 2021 2022 2023 2024 2025
+10.4% +55.3% +37.9% -32.1% -33.3% +71.4% +1.0%
+66.7% +64.6% -96.3% +160.5% +2.2% +2.0% +1.0%
-311.6% -32.1% -58.1% +173.3% -21.4%
+68.1% +63.2% +20.7% +24.5% -0.1% -6.0% -5.8%
+22.5% +73.3% +118.7% +28.7% -1.7% +0.1% -14.1%
+59.0% -73.2% +741.4% +25.6% -5.3% +2.1% -14.7%
-43.0% +74.5% +3.3% -38.0% -100.0%
+18.6% -22.1% +242.7% -178.1% -89.8% -7.6%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?